These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 14705152)

  • 21. Intensive nutritional counselling in bulimia nervosa: a role for supplementation with fluoxetine?
    Beumont PJ; Russell JD; Touyz SW; Buckley C; Lowinger K; Talbot P; Johnson GF
    Aust N Z J Psychiatry; 1997 Aug; 31(4):514-24. PubMed ID: 9272261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluoxetine and eating disorders.
    Morgan JF
    Hosp Med; 1999 Sep; 60(9):686. PubMed ID: 10621803
    [No Abstract]   [Full Text] [Related]  

  • 23. Challenges in conducting a multi-site randomized clinical trial comparing treatments for adolescent anorexia nervosa.
    Lock J; Brandt H; Woodside B; Agras S; Halmi WK; Johnson C; Kaye W; Wilfley D
    Int J Eat Disord; 2012 Mar; 45(2):202-13. PubMed ID: 21495052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of oral zinc sulfate effect on obsessive-compulsive disorder: a randomized placebo-controlled clinical trial.
    Sayyah M; Olapour A; Saeedabad Ys; Yazdan Parast R; Malayeri A
    Nutrition; 2012 Sep; 28(9):892-5. PubMed ID: 22465904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial.
    Davey CG; Chanen AM; Hetrick SE; Cotton SM; Ratheesh A; Amminger GP; Koutsogiannis J; Phelan M; Mullen E; Harrison BJ; Rice S; Parker AG; Dean OM; Weller A; Kerr M; Quinn AL; Catania L; Kazantzis N; McGorry PD; Berk M
    Lancet Psychiatry; 2019 Sep; 6(9):735-744. PubMed ID: 31371212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 1-year follow-up of a multi-center treatment trial of adults with anorexia nervosa.
    Yu J; Stewart Agras W; Halmi KA; Crow S; Mitchell J; Bryson SW
    Eat Weight Disord; 2011 Sep; 16(3):e177-81. PubMed ID: 22290033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does adjunctive fluoxetine influence the post-hospital course of restrictor-type anorexia nervosa? A 24-month prospective, longitudinal followup and comparison with historical controls.
    Strober M; Freeman R; DeAntonio M; Lampert C; Diamond J
    Psychopharmacol Bull; 1997; 33(3):425-31. PubMed ID: 9550888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A retrospective study of SSRI treatment in adolescent anorexia nervosa: insufficient evidence for efficacy.
    Holtkamp K; Konrad K; Kaiser N; Ploenes Y; Heussen N; Grzella I; Herpertz-Dahlmann B
    J Psychiatr Res; 2005 May; 39(3):303-10. PubMed ID: 15725429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using acute tryptophan depletion to investigate predictors of treatment response in adolescents with major depressive disorder: study protocol for a randomised controlled trial.
    Stewart RM; Hood SD; Rao P; Moore JK; Runions KC; Murphy SE; Wong JWY; Zepf FD
    Trials; 2018 Aug; 19(1):434. PubMed ID: 30097056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of anorexia nervosa with exercise and selective serotonergic reuptake inhibitors.
    Rosenblum J; Forman SF
    Curr Opin Pediatr; 2003 Jun; 15(3):346-7. PubMed ID: 12806270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Participant recruitment for an anorexia nervosa treatment study.
    McDermott C; Agras WS; Crow SJ; Halmi K; Mitchell JE; Bryson S
    Int J Eat Disord; 2004 Jan; 35(1):33-41. PubMed ID: 14705155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of selective serotonin reuptake inhibitors in eating disorders.
    Mayer LE; Walsh BT
    J Clin Psychiatry; 1998; 59 Suppl 15():28-34. PubMed ID: 9786308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.
    Barr LC; Goodman WK; Anand A; McDougle CJ; Price LH
    Am J Psychiatry; 1997 Sep; 154(9):1293-5. PubMed ID: 9286191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does percent body fat predict outcome in anorexia nervosa?
    Mayer LE; Roberto CA; Glasofer DR; Etu SF; Gallagher D; Wang J; Heymsfield SB; Pierson RN; Attia E; Devlin MJ; Walsh BT
    Am J Psychiatry; 2007 Jun; 164(6):970-2. PubMed ID: 17541059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorder.
    Shapira NA; Ward HE; Mandoki M; Murphy TK; Yang MC; Blier P; Goodman WK
    Biol Psychiatry; 2004 Mar; 55(5):553-5. PubMed ID: 15023585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial.
    Akhondzadeh S; Jafari S; Raisi F; Nasehi AA; Ghoreishi A; Salehi B; Mohebbi-Rasa S; Raznahan M; Kamalipour A
    Depress Anxiety; 2009; 26(7):607-11. PubMed ID: 19496103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluoxetine in social phobia: a double-blind, placebo-controlled pilot study.
    Kobak KA; Greist JH; Jefferson JW; Katzelnick DJ
    J Clin Psychopharmacol; 2002 Jun; 22(3):257-62. PubMed ID: 12006895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained response versus relapse: the pharmacotherapeutic goal for obsessive-compulsive disorder.
    Fineberg NA; Pampaloni I; Pallanti S; Ipser J; Stein DJ
    Int Clin Psychopharmacol; 2007 Nov; 22(6):313-22. PubMed ID: 17917549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Olanzapine Versus Placebo in Adult Outpatients With Anorexia Nervosa: A Randomized Clinical Trial.
    Attia E; Steinglass JE; Walsh BT; Wang Y; Wu P; Schreyer C; Wildes J; Yilmaz Z; Guarda AS; Kaplan AS; Marcus MD
    Am J Psychiatry; 2019 Jun; 176(6):449-456. PubMed ID: 30654643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluoxetine normalizes increased cardiac vagal tone in bulimia nervosa.
    Rissanen A; Naukkarinen H; Virkkunen M; Rawlings RR; Linnoila M
    J Clin Psychopharmacol; 1998 Feb; 18(1):26-32. PubMed ID: 9472839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.